Signals One™

Revvity SignalsAvailable: Worldwide

Make your innovations a reality with the first unified, cloud-native SaaS R&D solution that streamlines scientific complexity and promotes collaboration.

Request Pricing
Revvity Signals

Receive your quote directly from the manufacturer.

Ease of Use
After Sales Service
Value for Money
Be the first to leave a review
Description

Signals One™ is an end-to-end R&D workflow solution providing data capture & collaboration, data processing, and data-driven analytics.

Signals One is ideally suited to handle research use cases involving earlier stage in-vitro assays, later stage in-vitro assays, cell line optimization, biologics process optimization, in vitro DMPK assays, animal pharmacokinetic studies, stage animal efficacy and safety studies.

Benefits:

  • Signals One implements 24/7 global security monitoring, alerting, and escalation by the Revvity Signals Software Security Operations Center.
  • Signals One accelerates the drug discovery process for these novel therapeutics by providing tools for assay development, hit identification, and lead optimization.
  • Signals One is a fully integrated platform that encapsulates trusted products, avoiding the complexities and inefficiencies of a piecemeal, application-centric ecosystem.

Brochures

Product brochuresLife Sciences

An intelligent R&D data management software solution

This brochure introduces Signals One, an integrated data management platform designed to streamline R&D and formulation workflows in chemistry-driven industries. By unifying experimental data, analytics, and collaboration tools in a cloud-based environment, the platform helps address common challenges associated with fragmented data systems and manual processes. Signals One combines electronic lab notebook capabilities with advanced data visualization and modelling tools to support experiment planning, data analysis, and regulatory compliance. The solution enables faster decision making, reduces development timelines, and improves productivity in the development of new chemical products and formulations.


Signals One for new biological and chemical modalities research

Explore Signals One™, a unified, cloud‑native SaaS platform designed to support drug discovery research across emerging biological and chemical modalities. Signals One brings together design, experimentation, data capture, analytics, and decision‑making within a single workflow‑focused environment, helping scientists manage the complexity of modern R&D.

Discover how the platform integrates tools such as ChemDraw®, HELM notation for biomolecules, native and Spotfire‑powered analytics, and AI‑ready data infrastructure to enable collaboration across multidisciplinary teams. By connecting chemical and biological data throughout the Design‑Make‑Test‑Decide lifecycle, Signals One helps organizations reduce data silos, improve insight generation, and accelerate the progression of new therapeutic candidates.

Empowering modern research with electronic lab notebooks

This eBook explores how electronic lab notebooks (ELNs) are transforming modern research by improving data management, collaboration, and reproducibility. It highlights the shift from paper-based workflows to integrated digital platforms that connect experimental design, data capture, and analysis across teams. Featuring Signals™ Notebook, the eBook demonstrates how cloud-based ELNs can unify chemical and biological data, streamline documentation, and support decision-making throughout the drug discovery process.

Discover how by enabling structured data capture, real-time collaboration, and scalable workflows, ELNs help reduce inefficiencies, accelerate research timelines, and support more reliable and compliant scientific outcomes.


Building a unified design-make-test-decide approach to drug discovery

This resource explores how integrated digital platforms can improve efficiency and decision-making in modern drug discovery workflows. It highlights the transition from traditional design‑make‑test‑analyze cycles to a more dynamic design‑make‑test‑decide approach, enabling real-time insights across multidisciplinary teams.

The Signals One™ platform brings together molecule design, assay data, analytics, and experiment tracking in a unified environment, helping researchers connect data across workflows and reduce inefficiencies caused by fragmented systems. Discover how by supporting collaboration and providing actionable insights, the approach aims to accelerate candidate selection and improve outcomes in complex therapeutic development.


Building stronger AI foundations for drug discovery

This resource explores how the success of artificial intelligence in drug discovery depends on the quality, structure, and governance of underlying data. It highlights how fragmented, incomplete, or biased datasets can limit AI performance, and outlines approaches to improve data readiness through FAIR principles, standardization, and collaborative frameworks such as federated learning.

Explore how platforms like Signals One™ enable researchers to unify and structure data across workflows, supporting more reliable AI‑driven insights and accelerating decision‑making in drug development.

Transforming formulation science with the innovation of Signals One

July 24, 2025, 16:00 BST / 17:00 CEST / 11:00 EDT / 8:00 PDT

In today’s fast-paced formulation science landscape, the ability to seamlessly capture, manage, and share experimental data is a critical driver of innovation. Equipping researchers with secure and accurate software, accelerates workflows and unlocks the full potential of every experiment.

Join Revvity Signals experts, Marie Jué, Sr. Field Application Scientist and Jun Liu, Senior Marketing Manager, as they deep dive into a software that streamlines formulation workflows in R&D. Discover how the Signals One™ platform can reduce reliance on spreadsheets, minimize errors, and accelerate decision-making with built-in scientific intelligence.

Plus, hear real-world stories of how scientists have utilized this platform to capture, analyze, and visualize formulation data with greater accuracy and speed to drive their research forward.

Key learning objectives

  • Understand how Signals One streamlines formulation workflows by integrating data capture, analysis, and visualization into a single, purpose-built platform.
  • Learn how to reduce errors and increase productivity by moving beyond traditional spreadsheet-based methods to a more reliable, scientifically intelligent system.
  • Explore real-world use cases demonstrating how formulation scientists accelerate decision-making and scale successful formulations using Signals One.

Who should attend?

  • Formulation scientists, R&D managers and directors, laboratory data analysts, and R&D digital transformation leaders.

Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.


WebinarMaterials

TechTalk: Transforming formulation science with Signals One Software

Friday, June 12 at 15:00 BST | 16:00 CEST | 10:00 EDT | 7:00 PDT

Modern formulation development demands more than spreadsheets. It requires intelligent software that unifies data management, chemistry intelligence, and advanced analytics. This SelectScience® TechTalk demonstrates how Signals One addresses the escalating complexity of formulation science, where dozens of input factors, non-linear relationships, and regulatory/sustainability constraints generate massive experimental datasets requiring sophisticated analysis.

Attendees will discover how this platform combines powerful formulation table management with project coordination, material library integration, automated instrument data capture, and chemistry-aware capabilities through embedded ChemDraw functionality.

Whether you are in coatings, polymers, or cosmetics, this TechTalk will reveal how Signals One accelerates R&D cycles by transforming dispersed data into actionable insights helping teams make faster, data-driven decisions while maintaining complete traceability from formulation design through scale-up.

Certificate of attendance
If you attend the live TechTalk, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

If you view the on-demand TechTalk, you can request a certificate of attendance by emailing editor@selectscience.net.

TechTalk details

  • Cost: Free to attend
  • Location: Online
  • Duration: 20 minutes

Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.


How smarter data management and machine‑learning‑driven design of experiments accelerate formulation development

Monday, June 29 at 16:00 BST | 17:00 CEST | 11:00 EDT | 8:00 PDT

Formulation development is becoming increasingly complex, and traditional spreadsheet‑based approaches often struggle to keep up with multidimensional ingredient interactions and growing sustainability demands. Today’s R&D teams need modern, data‑driven technologies that simplify experimentation and speed up decision‑making.

In this SelectScience® webinar join Dr. Tom Whiteheads, Head of Machine learning at Intellegens and Jun Liu from Revvity Signals to discover how emerging digital and machine‑learning approaches can cut experimental workload by 50–80% while accelerating insight generation. Dr. Whiteheads and Liu will introduce a new technological pathway for formulation science built around unified digital workflows and Adaptive Experimental Design (AED), a machine learning–driven method for navigating complex formulation spaces.

You will explore how to bring together formulation data management, material libraries, automated data capture, and chemistry‑aware tools such as embedded ChemDraw, while using AED to iteratively optimize formulations and processes. Together, the speakers will highlight how these capabilities help accelerate R&D, turn fragmented data into actionable insights, and support faster, more efficient, and more sustainable formulation development.

Certificate of attendance

If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.

Webinar details

  • Cost: Free to attend
  • Location: Online
  • Duration: 60 minutes per session

Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available


Navigating the new era of GxP compliance with smarter digital workflows

Tuesday, June 16 at 16:00 BST | 17:00 CEST | 11:00 EDT | 08:00 PDT

Pharmaceutical and biopharmaceutical teams working in GxP‑regulated environments are navigating growing regulatory demands, legacy system limitations, and the need to modernize digital workflows while maintaining strict compliance with global standards such as 21 CFR Part 11, Annex 11, and broader GxP frameworks. As these pressures intensify, many organizations are seeking clearer strategies and proven approaches to evolve their systems without introducing compliance risk.

In this SelectScience® webinar, GxP experts Ankita Dhar and Jenny Lesinski from Revvity Signals will share practical strategies for streamlining compliant workflows, strengthening data integrity, and reducing the burden of computer system validation using a portfolio of solutions including Signals One™. They will also spotlight real-world stories that illustrate the challenges teams face, from managing complex validation cycles to adapting to shifting regulatory expectations, and how those organizations successfully addressed them.

Whether you are exploring new digital solutions or looking to optimize existing regulated workflows, this session will equip you with actionable insights to enhance compliance, improve efficiency, and support long-term operational excellence.

Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.

Webinar details

  • Cost: Free to attend
  • Location: Online
  • Duration: 60 minutes

Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.

Product Overview

Links